about
A population pharmacokinetic model for vancomycin in pediatric patients and its predictive value in a naive population.Population pharmacokinetic analysis of vancomycin in patients with hematological malignanciesPopulation pharmacokinetic analysis of vancomycin in neonates. A new proposal of initial dosage guideline.Population pharmacokinetics of ciprofloxacin in neonates and young infants less than three months of age.Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearanceClinical pharmacokinetics of vancomycin in the neonate: a reviewPharmacokinetic studies in infants using minimal-risk study designsTowards Rational Dosing Algorithms for Vancomycin in Neonates and Infants Based on Population Pharmacokinetic Modeling.Pharmacodynamics of vancomycin for CoNS infection: experimental basis for optimal use of vancomycin in neonates.External Evaluation of Population Pharmacokinetic Models of Vancomycin in Neonates: The transferability of published models to different clinical settings.Vancomycin: a review of population pharmacokinetic analyses.Population pharmacokinetic analysis during the first 2 years of life: an overview.How to use vancomycin optimally in neonates: remaining questions.Renal Function Descriptors in Neonates: Which Creatinine-Based Formula Best Describes Vancomycin Clearance?Pharmacometric Approaches to Personalize Use of Primarily Renally Eliminated Antibiotics in Preterm and Term Neonates.Evaluation of Vancomycin Use in Late-Onset Neonatal Sepsis Using the Area Under the Concentration-Time Curve to the Minimum Inhibitory Concentration ≥400 Target.Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring.Pediatric pharmacokinetics of vancomycin: a canadian perspective.Pharmacokinetics and dose requirements of vancomycin in neonates.Vancomycin monitoring in term newborns: comparison of peak and trough serum concentrations determined by high performance liquid chromatography and fluorescence polarization immunoassay.The kinetic profile of vancomycin in neonates.
P2860
Q33978650-8684C674-E2F2-44C7-AC53-464ACEF2E509Q34228227-D47A92A5-A600-4D5B-971F-EA1172EF3B7AQ34381352-7E692181-5674-440D-830E-1C2F928C3246Q34596303-80778C52-0446-4B5E-9A19-005502CD15FAQ36024899-4BE55B8F-328E-465F-A59C-DBE8B1056D26Q36104107-0A43F0D0-8E26-48B7-B42A-B0BEBED0CE47Q36438116-52501590-0D4B-462D-B3B2-F4504A8467A2Q36571794-3144AFBF-AF15-4647-B10C-619B07A4A274Q36684184-FE65C675-D468-4064-A483-2883169DA731Q36729959-938232B4-A174-4BDB-A46D-1DECF00559C0Q37965578-AE79C3CE-E9BA-4EE2-B9E7-F5FA513C4BC3Q38062388-20411263-1E03-4774-AA54-04D3448F85D6Q38569678-8399AA70-7FA7-4FF9-BB0C-F96E1F76A1B8Q38594191-6D08AB51-24A8-42B6-84EE-96CC661EC66AQ38696468-E7B36272-82F9-411B-AA92-CCB9558C7018Q40327439-56E1BAE2-1EB7-44BF-905C-414F4E329B4CQ42282104-5F7C2473-FF23-4F3B-BA44-D5016C43965FQ42732800-080C88F0-D647-4186-A5ED-9C9E674F42F7Q43097632-4B63054E-7975-4DB4-9432-227361D952D2Q43848071-CB1BF87E-1DC2-4DA1-83BC-8B96BA493313Q52180861-C1C6351C-595A-40B4-B4CD-2B7BA8705843
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Population pharmacokinetics of vancomycin in neonates.
@en
Population pharmacokinetics of vancomycin in neonates.
@nl
type
label
Population pharmacokinetics of vancomycin in neonates.
@en
Population pharmacokinetics of vancomycin in neonates.
@nl
prefLabel
Population pharmacokinetics of vancomycin in neonates.
@en
Population pharmacokinetics of vancomycin in neonates.
@nl
P2093
P356
P1476
Population pharmacokinetics of vancomycin in neonates.
@en
P2093
P304
P356
10.1038/CLPT.1994.120
P407
P577
1994-08-01T00:00:00Z